High Incidence of Endocrine-related Diseases Propels Global Endocrinology Drugs Market


Published Date : May 09, 2016

Albany, New York, May 09, 2016 – MarketResearchReports.biz has recently added a new research report to its massive repository. The research report, titled “Global Endocrinology Drugs Market 2016-2020,” studies the overall endocrinology market and highlights the various trends and dynamics influencing the market. Furthermore, it also assesses the market using a SWOT reports to determine the strengths, weaknesses, opportunities, and threats influencing the segments of this market. The segmentation by application studies the demand for endocrinology drugs in global diabetes drugs market, global testosterone replacement therapy market, and global thyroid hormone disorder drugs market amongst others. Additionally, the research report also includes Porter’s five forces reports to shed light on the threat of new entrants, the bargaining power of customers, the bargaining power of suppliers, the intensity of competitive rivalry, and the threat of substitute products or services.

Endocrinology is the study of endocrine system that includes the physiological and biochemical functions of the cells, tissues, and hormones of the endocrine glands. Any kind of an impairment to the endocrine system can lead to endocrine gland hypersecretion that can lead to excess hormone secretion or endocrine gland hyposecretion, which can result in a hormone deficiency and tumor formation in the endocrine gland. The possibilities of endocrine disorders are oftentimes a result of diabetes, thyroid disorders, human growth hormone deficiency, and male hypogonadism.

According to the research report, the global endocrinology drugs market is expected to surge at a CAGR of 6.69% between 2016 and 2020. This market has been segmented on the basis drugs into branded drugs, biosimilars, and generics. On the basis of diseases, this market is segmented into hypogonadism, type 1 and type 2 diabetes, thyroid gland disorders, and human growth hormone deficiency. Geographically, this market is segmented into the Americas, Europe, the Middle East and Africa, and the Asia Pacific.

For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/711552

The growth of the global endocrinology drugs market will be attributable to the high incidence of endocrine hormone-related diseases. The ongoing trend of outsourcing the manufacturing of drugs is also expected accelerate the growth of this market. However, the global endocrinology drugs market faces a tough challenge of generic erosion.

The important players in the global endocrinology drugs market are AbbVie Inc., AstraZeneca PLC, Eli Lilly and Co., Merck & Co, Novo Nordisk AS, and Sanofi SA. The research report profiles these players and provides a fair study of the competitive landscape of the overall market. Furthermore, the research report also gives its readers a take on the investment outlook, research and development strategies, financial overview, list of existing products and those in the pipeline, and expansion plans of these top players for the coming few years. The research report is complete with figures, tables, charts, and other pictorial explanations of the overall market to help the readers determine its future in an objective manner.

To order report Call Toll Free: 866-997-4948 or send an email on sales@marketresearchreports.biz